We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,517 results
  1. Minimum latency effects for cancer associated with exposures to radiation or other carcinogens

    Background

    In estimating radiation-associated cancer risks a fixed period for the minimum latency is often assumed. Two empirical latency functions...

    Mark P. Little, Markus Eidemüller, ... A. Iulian Apostoaei in British Journal of Cancer
    Article 11 January 2024
  2. A cell cycle centric view of tumour dormancy

    Tumour dormancy and recurrent metastatic cancer remain the greatest clinical challenge for cancer patients. Dormant tumour cells can evade treatment...

    William A. Weston, Alexis R. Barr in British Journal of Cancer
    Article Open access 22 August 2023
  3. Human cytomegalovirus DNA detection in a recurrent glioblastoma multiforme tumour, but not in whole blood: a case report and discussion about the HCMV latency and therapy perspectives

    In the current study, a 58-year-old male patient presented with recurrent glioblastoma multiforme (GBM). The patient underwent surgical resection,...

    Emiliya Nikolova, Petia Dimova, ... Albena Todorova in Journal of NeuroVirology
    Article 03 September 2020
  4. SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53

    Background

    Mutational inactivation of the SETDB1 histone methyltransferase is found in a subset of mesothelioma, particularly in cases with...

    Mengting Xu, Yuqing Tu, ... Wen-Bin Ou in British Journal of Cancer
    Article 27 June 2023
  5. C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer

    Background

    This study aimed to investigate the expression and clinical significance of Dendritic cell-associated C-type lectin-1 (Dectin-1) in gastric...

    **n Liu, Kunpeng Lv, ... Jiejie Xu in British Journal of Cancer
    Article Open access 08 July 2023
  6. Role of Tumour-Associated Macrophages in Colon Cancer Progression and Its Therapeutic Targeting

    Cancer tissues are invariably infiltrated by cells of the immune system, and macrophages constitute the major portion of these. Experimental pieces...
    Arundhati Mehta, Vivek Kumar Soni, ... Naveen Kumar Vishvakarma in Colon Cancer Diagnosis and Therapy Vol. 3
    Chapter 2022
  7. Remodelling of the tumour microenvironment by the kallikrein-related peptidases

    Kallikrein-related peptidases (KLKs) are critical regulators of the tumour microenvironment. KLKs are proteolytic enzymes regulating multiple...

    Srilakshmi Srinivasan, Thomas Kryza, ... Judith Clements in Nature Reviews Cancer
    Article 31 January 2022
  8. Vessel co-option and angiotropic extravascular migratory metastasis: a continuum of tumour growth and spread?

    Two fields of cancer research have emerged dealing with the biology of tumour cells localised to the abluminal vascular surface: vessel co-option...

    Claire Lugassy, Peter B. Vermeulen, ... Raymond L. Barnhill in British Journal of Cancer
    Article 05 January 2022
  9. The role of ROS in tumour development and progression

    Eukaryotic cells have developed complex systems to regulate the production and response to reactive oxygen species (ROS). Different ROS control...

    Eric C. Cheung, Karen H. Vousden in Nature Reviews Cancer
    Article 31 January 2022
  10. Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study

    The mouse mammary tumour virus (MMTV) is implicated in the aetiology of murine mammary carcinomas and a variant of it, the type B leukemogenic virus,...

    Francesca Parisi, Francesca Lessi, ... Alessandro Poli in Infectious Agents and Cancer
    Article Open access 23 June 2022
  11. Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker

    Immune-checkpoint inhibitors have shown modest efficacy against immunologically ‘cold’ tumours. Interleukin-12 (IL-12)—a cytokine that promotes the...

    Aslan Mansurov, Peyman Hosseinchi, ... Jeffrey A. Hubbell in Nature Biomedical Engineering
    Article 09 May 2022
  12. Loss of RPTPγ primes breast tissue for acid extrusion, promotes malignant transformation and results in early tumour recurrence and shortened survival

    Background

    While cellular metabolism and acidic waste handling accelerate during breast carcinogenesis, temporal patterns of acid–base regulation and...

    Rasmus A. Sloth, Trine V. Axelsen, ... Ebbe Boedtkjer in British Journal of Cancer
    Article 11 July 2022
  13. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity

    Radiotherapy (RT) is a highly effective anticancer treatment that is delivered to more than half of all patients with cancer. In addition to the...

    Urszula M. Cytlak, Douglas P. Dyer, ... Timothy M. Illidge in Nature Reviews Immunology
    Article 01 July 2021
  14. ROS and TGFβ: from pancreatic tumour growth to metastasis

    Transforming growth factor β (TGFβ) signalling pathway switches between anti-tumorigenic function at early stages of cancer formation and...

    Chao-Hui Chang, Siim Pauklin in Journal of Experimental & Clinical Cancer Research
    Article Open access 03 May 2021
  15. Prostate cancer genetic propensity risk score may modify the association between this tumour and type 2 diabetes mellitus (MCC-Spain study)

    Background

    Some studies have reported an inverse association between type 2 diabetes mellitus (T2DM) and prostate cancer (PCa), but results on this...

    Rocío Barrios-Rodríguez, Esther García-Esquinas, ... José Juan Jiménez-Moleón in Prostate Cancer and Prostatic Diseases
    Article 02 October 2021
  16. Autophagy and Tumour Chemotherapy

    Chemotherapy is an important means of treating malignant tumours. The main role of chemotherapy drugs is to induce cell death. However, the apoptotic...
    **aojuan Hou, **ghua Jiang, ... Lixin Wei in Autophagy: Biology and Diseases
    Chapter 2020
  17. Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada

    Background

    Studies to date have yielded inconclusive results as to whether maternal medical history during pregnancy, and a child’s early-life medical...

    Sierra Cheng, John R. McLaughlin, ... Rayjean J. Hung in British Journal of Cancer
    Article 10 May 2023
  18. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

    Background

    The Tumor Microenviroment (TME) is a complex milieu that is increasingly recognized as a key factor in multiple stages of disease...

    Massimo Granai, Lucia Mundo, ... Teresa Marafioti in Infectious Agents and Cancer
    Article Open access 06 May 2020
  19. Hypoxia and the Metastatic Cascade

    Metastasis is a leading cause of mortality in cancer patients. The journey of a detached primary tumour cell to a secondary homing site is a...
    Sanchit Gandhi, Shruti Khanna, ... Tapasya Srivastava in Hypoxia in Cancer: Significance and Impact on Cancer Therapy
    Chapter 2023
  20. Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model

    Objective

    There is substantial evidence that exercise can safely reduce the risk of cancer and improve survival in different human cancer populations....

    Scott A. Fisher, Carolyn J. Peddle-McIntyre, ... Anna K. Nowak in BMC Research Notes
    Article Open access 15 September 2020
Did you find what you were looking for? Share feedback.